HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Fmr LLC

Fmr LLC decreased its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 0.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,290,116 shares of the company’s stock after selling 39,723 shares during the period. Fmr LLC owned about 6.06% of HealthEquity worth $432,996,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also modified their holdings of the company. Price T Rowe Associates Inc. MD boosted its holdings in HealthEquity by 7.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 51,384 shares of the company’s stock valued at $4,195,000 after purchasing an additional 3,365 shares during the period. GAMMA Investing LLC grew its position in shares of HealthEquity by 114.8% during the second quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock worth $51,000 after buying an additional 318 shares in the last quarter. CWM LLC increased its stake in shares of HealthEquity by 6.9% during the second quarter. CWM LLC now owns 3,958 shares of the company’s stock worth $341,000 after buying an additional 255 shares during the period. SG Americas Securities LLC raised its holdings in HealthEquity by 48.5% in the second quarter. SG Americas Securities LLC now owns 3,798 shares of the company’s stock valued at $327,000 after acquiring an additional 1,241 shares in the last quarter. Finally, Sequoia Financial Advisors LLC purchased a new position in HealthEquity in the second quarter worth approximately $1,122,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the completion of the transaction, the director now owns 54,719 shares in the company, valued at approximately $4,540,582.62. This represents a 13.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Frank Corvino sold 1,039 shares of HealthEquity stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the sale, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. The trade was a 21.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 10,536 shares of company stock valued at $884,517 over the last quarter. 2.20% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on HQY shares. Royal Bank of Canada reissued an “outperform” rating and issued a $92.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Bank of America lifted their price target on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Barrington Research reaffirmed an “outperform” rating and set a $105.00 price objective on shares of HealthEquity in a research report on Friday, September 20th. Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Finally, BTIG Research upped their price target on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $107.23.

HealthEquity Price Performance

HQY stock opened at $101.54 on Friday. The business has a 50 day simple moving average of $89.72 and a 200-day simple moving average of $82.60. The company has a market capitalization of $8.87 billion, a P/E ratio of 84.62, a PEG ratio of 1.60 and a beta of 0.52. HealthEquity, Inc. has a twelve month low of $62.10 and a twelve month high of $105.82. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.16. The company had revenue of $299.93 million for the quarter, compared to the consensus estimate of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. As a group, equities analysts anticipate that HealthEquity, Inc. will post 2.27 EPS for the current year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.